Safety Trial of New Antibiotic - YouTube
Overview of microbiome dynamics during gepotidacin Phase 2a clinical... | Download Scientific Diagram
Dose Selection for Phase 3 Studies Evaluating Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | GSK
Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase | ACS Infectious Diseases
Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | Antimicrobial Agents and Chemotherapy
Antibiotics | Free Full-Text | Antibacterial Activity of the Novel Drug Gepotidacin against Stenotrophomonas maltophilia—An In Vitro and In Vivo Study
Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | Antimicrobial Agents and Chemotherapy
TITLE PAGE
How to Treat Urinary Tract Infections (UTI): GSK's Gepotidacin May Work - Bloomberg
With endpoints already met, GSK halts trial into new antibiotic
TITLE PAGE
Dose Selection for Phase 3 Studies Evaluating Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | GSK
First Novel Antibiotic Since 20 Years, Gepotidacin Debuts To Treat Drug Resistance Urinary Tract Infections (UTIs) Amidst Growing Incidences! - Thailand Medical News
Gepotidacin for Urinary Tract Infection Clinical Trial 2023 | Power
GSK to submit drug application for new antibiotic to US FDA - PMLiVE
Gepotidacin (GSK2140944) Demonstrates Similar Safety and Pharmacokinetics in Adults and Adolescents (12 to ˂18 years) | GSK
Dose Selection for a Phase 3 Study Evaluating Gepotidacin (GSK2140944) in the Treatment of Gonorrhoea | GSK
New Urinary Tract Infections Clinical Trial: Gepotidacin for Urinary Tract Infections - YouTube
Dose Selection for a Phase 3 Study Evaluating Gepotidacin (GSK2140944) in the Treatment of Gonorrhoea | GSK
Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea | Sexually Transmitted Infections
Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase | ACS Infectious Diseases
Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants | SpringerLink
